LONDON: Smiths Group plc has announced the appointment of JehanZeb Noor as Chief Executive Officer (CEO) of Smiths Medical. JehanZeb will be part of Smiths Group’s Executive Committee and report to Andy Reynolds Smith, CEO of Smiths Group plc.
[the_ad id=”32940″]JehanZeb will take up the role on 1 July 2019 and will oversee the separation of Smiths Medical, which is expected to be completed during the first half of CY2020.
JehanZeb joins from Amcor Flexibles Inc. (‘Amcor’), where he led the Healthcare North America business and Global Sales for Medical. Amcor is a specialist producer of sterile packaging for the global medical device and pharmaceuticals industries. During his three-year tenure at Amcor he drove a significant improvement in margin and revenue growth and led the integration of a major acquisition. Prior to joining Amcor, JehanZeb was a Partner at McKinsey & Company where he served for 9 years. He has a deep understanding of the MedTech supply chain, operations, distribution, product development and regulatory approval processes. JehanZeb holds a BSc in Finance and a BSc and MSc in Mechanical Engineering from the Massachusetts Institute of Technology.
JehanZeb Noor, Smiths Medical Chief Executive Officer Designate, commented: “Smiths Medical is an industry leader, offering high quality specialised medical devices across the globe with significant investment in new products. The company will begin an exciting new chapter when it separates from the wider Group and I’m looking forward to the opportunity to join the team and lead the journey ahead to achieve our full potential, while serving a life saving mission.”